The iCare project had its kick-off meeting at the INL offices in Braga on the 15 and 16th of February

iCare - Integrated assessment and Advanced Characterisation of Neuro-Nanotoxicity - is  a project funded by the European Commission under the HORIZON-CL4-2022-DIGITAL-EMERGING-01 and coordinated by the Nanosafety Research group, INL.

iCare focuses on assessing the physical-chemistry characteristics of ANMC in complicated matrices and seeks to provide a robust and adaptable collection of sophisticated imaging technologies.

The primary goal will be on an integrated model system to characterise and forecast how nanomaterials may affect brain health to prevent nanomaterial toxicity.

The project offers tools and procedures for assessing changes in the shape, chemical content, and reactivity of nanomaterials available to the industry.

With a focus on high-resolution imaging methodologies, the project makes a variety of techniques and methods for evaluating changes in morphology, chemical composition, and reactivity of nanomaterials when exposed to complex homogenous matrices that mimic environmental and biological exposure available to industry.

To accomplish this, the consortium includes 11 partners from various backgrounds, including RTOs, SMEs, industries, and universities from different EU and non-EU countries, as well as those working in nanotechnology, toxicology, advanced materials, and advanced imaging.

Partners had the chance to meet each other and exchange ideas on the first steps of the project towards success.